ValuentumAd

Official PayPal Seal

Domestic Pharma Drives JNJ's 1Q; Stock Hits All-Time High

publication date: Apr 19, 2016
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.


Johnson & Johnson reported strong growth in its Pharmaceutical segment in the first quarter of 2016. The underlying strength allowed the firm to raise its full-year forecasts after adjusting its outlook on currency expectations for the year.


Subscribe Now to Gain Access!

This page is available to subscribers only. To gain access to members only content (including this research piece), click here to subscribe. With a subscription, you'll have access to all of our premium commentary, equity reports, dividend reports and Best Ideas Newsletter and Dividend Growth Newsletter, as well as receive discounts on all of our modeling tools and products. Financial advisers and institutional investors have even more to choose from!

Click to Learn More about Valuentum

If you are already a subscriber, please login.

If you believe you should be able to view this area then please contact us and we will try to rectify this issue as soon as possible.


To gain access to the members only content, click here to subscribe. You will be given immediate access to premium content on the site.